A pair of Rutgers professors have partnered with a former colleague to form a startup with the goal of developing novel cancer treatments based on the use of antibody drug conjugates.
In an effort to expand and enhance New Jersey’s research and innovation ecosystem, Rutgers Office for Research’s Innovation Ventures will participate in a technology transfer partnership with the New Jersey Association of State Colleges and Universities (NJASCU).
Rutgers Office for Research’s Innovation Ventures has executed an exclusive license agreement between the university and Sauvie BiKE, LLC, a subsidiary of Sauvie Inc., to develop and commercialize a bi-specific natural killer cell engager technology in the field of oncology.
Maria Laura ‘Marila’ Gennaro, a professor of medicine at Rutgers New Jersey Medical School and a professor of epidemiology at Rutgers School of Public Health, has been named a National Academy of Inventors Fellow, which is the highest professional distinction accorded solely to academic inventors. The NAI Fellows Program highlights academic inventors who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on quality of life, economic development, and the welfare of society.
A drone that can fly, float, swim, dive, and transition between air and water in less than a second. Technology that can change the genetic code at the individual base level in a cell or an organism. These two innovations, both invented at Rutgers, The State University of New Jersey, received 2022 Edison Patent Awards at the Research & Development Council of New Jersey annual banquet on Thursday, Nov. 3.
Rutgers Office for Research was well-represented at the New Jersey Equity in Commercialization Collective (NJECC) annual conference at NJIT’s Campus Center in Newark, NJ.
Rutgers Innovation Ventures has executed an exclusive license between Rutgers, The State University of New Jersey and the startup RenewCO2.